These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15778602)

  • 1. Ocular surface squamous neoplasia: a standard of care survey.
    Stone DU; Butt AL; Chodosh J
    Cornea; 2005 Apr; 24(3):297-300. PubMed ID: 15778602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012.
    Adler E; Turner JR; Stone DU
    Cornea; 2013 Dec; 32(12):1558-61. PubMed ID: 24145630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
    Kim BH; Kim MK; Wee WR; Oh JY
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular surface squamous neoplasia after corneal graft.
    Ramasubramanian A; Shields CL; Sinha N; Shields JA
    Am J Ophthalmol; 2010 Jan; 149(1):62-5. PubMed ID: 19846060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical chemotherapy for ocular surface squamous neoplasia: current status.
    Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
    Br J Ophthalmol; 2010 May; 94(5):532-5. PubMed ID: 19776089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
    Galor A; Karp CL; Oellers P; Kao AA; Abdelaziz A; Feuer W; Dubovy SR
    Ophthalmology; 2012 Oct; 119(10):1974-81. PubMed ID: 22704832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
    Ma IH; Hu FR; Wang IJ; Chen WL; Hsu YJ; Chu HS; Yuan CT; Hou YC
    J Formos Med Assoc; 2019 Apr; 118(4):776-782. PubMed ID: 30266199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined surgery, cryotherapy, and mitomycin-C for recurrent ocular surface squamous neoplasia.
    Khokhar S; Soni A; SinghSethi H; Sudan R; Sony P; Pangtey MS
    Cornea; 2002 Mar; 21(2):189-91. PubMed ID: 11862092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.